← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Elusys Therapeutics, Inc.
Pine Brook, NJ
$11,772,026
Total funding
4
Grants
Funding over time
peak $4.4M · FY2005–08$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
Funding mix
By agency
NIH$11,772,026 · 4
By mechanism
UC1$9,598,770 · 2
U01$1,289,693 · 1
N01$883,563 · 1
Investigators at Elusys Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Monoclonal Antibody for Treatment of Inhalation Anthrax$5,000,000
UC1 · FY2004 · AI
Formulation Development for an Intramuscular Administer*$4,407,655
UC1 · FY2005 · AI
Advanced Development of Anthim$883,563
N01 · FY2008 · AI
Heteropolymer System to Treat Vaccinia Complications$649,429
U01 · FY2003 · AI
Heteropolymer System to Treat Vaccinia Complications$640,264
U01 · FY2004 · AI
Monoclonal Antibody for Treatment of Inhalation Anthrax$161,332
UC1 · FY2006 · AI
Monoclonal Antibody for Treatment of Inhalation Anthrax$29,783
UC1 · FY2006 · AI